Beacon Hospital

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Prostate cancer3 trials
• Lung cancer2 trials

Phase

• Phase 35 trials

Status

• Recruiting3 trials
• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• University of Sydney2 trials
• Bristol-Myers Squibb1 trial
• European Organisation for Research and Treatment of Cancer - EORTC1 trial
• Mirati Therapeutics Inc.1 trial

Running trials

• Recruiting

  Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors

  NCT05974774· Phase 3· European Organisation for Research and Treatment of Cancer - EORTC· Source

• Recruiting

  A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

  NCT06875310· Phase 3· Mirati Therapeutics Inc.· Source

• Recruiting

  A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

  NCT06561386· Phase 3· Bristol-Myers Squibb· Source

• Active, not recruiting

  Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate

  NCT04136353· Phase 3· University of Sydney· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer2 recruiting
• Prostate cancer1 recruiting

Closed trials

• Active, not recruiting

  Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer

  NCT02446444· Phase 3· University of Sydney· Source